Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: Results of a double-blind placebo-controlled trial

British Journal of Dermatology

Volumn 151, Issue 2, 2004, Pages 489-491

  Vahlquist, A ^a   Torma H ^a   Carlsson, B ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Karo Bio   (Sweden)

Author keywords

Clinical trial; Psoriasis; Thyroid hormone; Topical treatment

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE; THYROID HORMONE DERIVATIVE; TIRATRICOL; TRICANA;

ADULT; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PRURITUS; PSORIASIS VULGARIS; REMISSION; SELF EVALUATION; SIDE EFFECT; SKIN INDURATION; STATISTICAL SIGNIFICANCE; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PSORIASIS; TREATMENT FAILURE; TRIIODOTHYRONINE;

EID: 4544385700     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06037.x     Document Type: Article

References (8)

1. Blumenberg M, Connolly DM, Freedberg IM. Regulation of keratin gene expression: the role of the nuclear receptors for retinoic acid, thyroid hormone, and vitamin-D3. J Invest Dermatol 1992; 98: S42-9.
2. Törmä H, Karlsson T, Michaëlsson G et al. Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin. Acta Derm Venereol 2000; 80: 4-9.
3. Bracco D, Morin O, Schutz Y et al. Comparision of the metabolic and endocrine effects of 3,5,3-triiodothyroacetic acid and thyroxine. J Clin Endocrinol Metab 1993; 77: 221-8.
4. Radetti G, Persani L, Molinaro G et al. Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 1997; 7: 775-8.
5. Liang H, Juge-Aubry C, O'Conell M et al. Organ-specific effects of 3,5,3′-triiodothyroacetic acid in rats. Eur J Endocrinol 1997; 13: 537-44.
6. Faergemann J, Särnhult T, Hedner E et al. Dose-response effects of tri-iodothyroacetic acid (Triac) and other thyroid hormone analogues on glucocorticoid-induced skin atrophy in the haired mouse. Acta Derm Venereol 2002; 82: 179-83.
7. Dumas K, Scholtz J. The psoriasis bio-assay for topical corticosteroid acitivity. Acta Derm Venereol (Stockh) 1972; 52: 43-8.
8. Safer J, Fraser L, Ray S et al. Topical triiodothyronine stimulates epidermal proliferation, dermal thickening and hair growth in mice and rats. Thyroid 2001; 11: 717-24.